The present study confirms the anti-tumorigenic effects of 18α-GA on NSCLC, thereby inhibiting proliferation and metastasis of lung cancer cells by inducing apoptosis and inhibiting cell cycle progression, EMT, and regulating EGFR-PI3K/AKT signaling pathway. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.